Entrada Therapeutics Inc (TRDA)
17.07
+0.63
(+3.83%)
USD |
NASDAQ |
Oct 04, 16:00
17.08
+0.01
(+0.06%)
After-Hours: 20:00
Entrada Therapeutics Shareholders Equity (Annual): 242.36M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 242.36M |
December 31, 2022 | 212.55M |
December 31, 2021 | 298.72M |
Date | Value |
---|---|
December 31, 2020 | -41.49M |
December 31, 2019 | -15.52M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-41.49M
Minimum
2020
298.72M
Maximum
2021
139.32M
Average
212.55M
Median
2022
Shareholders Equity (Annual) Benchmarks
Fulcrum Therapeutics Inc | 235.19M |
Sarepta Therapeutics Inc | 859.34M |
Catalyst Pharmaceuticals Inc | 387.88M |
Vertex Pharmaceuticals Inc | 17.58B |
Regenxbio Inc | 311.74M |